ArticleJAMA ophthalmology2019

The Case for Extended Screening Intervals for People With Diabetes and No or Minimal Retinopathy at Baseline.

Peter van Wijngaarden et al.PubMed ↗Publisher ↗

No numbers read from the abstract.